Real‐life effectiveness of MP‐AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy

INTRODUCTION: Most allergic rhinitis (AR) patients have moderate‐to‐severe, persistent disease. Meda Pharma's AzeFlu (MP‐AzeFlu) combines intranasal azelastine hydrochloride (AZE) and fluticasone propionate (FP) in a novel formulation in a single device to treat AR. This prospective, noninterve...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaulsay, Ranbir, Nguyen, Duc Tung, Kuhl, Hans Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247236/
https://www.ncbi.nlm.nih.gov/pubmed/30306729
http://dx.doi.org/10.1002/iid3.237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247236/
https://www.ncbi.nlm.nih.gov/pubmed/30306729
http://dx.doi.org/10.1002/iid3.237

Ejemplares similares